Healthy Skepticism Library item: 7268
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
Zehr L.
Caution emerges over inhalable insulin
The Globe and Mail 2006 Oct 30
http://www.theglobeandmail.com/servlet/Page/document/v5/content/subscribe?user_URL=http://www.theglobeandmail.com%2Fservlet%2Fstory%2FLAC.20061030.RINSULIN30%2FTPStory%2FBusiness&ord=1166940869317&brand=theglobeandmail&force_login=true
Abstract:
The air is leaking out of what was supposed to be the next big thing in the treatment of diabetes: inhalable insulin.“While inhalable insulins will see a reasonable level of uptake, they aren’t the surefire blockbuster they were hyped to be,” says a new study by British market research firm Datamonitor PLC. It points out that the new treatment isn’t significantly better than existing therapies, is expensive and its long-term safety in the lungs is unknown.
